<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">MST1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>MST1</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>STK4, KRS2, MACROPHAGE STIMULATING 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>19p13.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6789</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>604995</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000101189</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q13043</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>487 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~56 kDa</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Small molecule inhibitors</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Kinase inhibitors</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Experimental</td>
</tr>
<tr>
<td class="label">Natural compounds</td>
<td>Investigation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's Disease</a>, <a href="/wiki/alzheimer'
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">MST1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>MST1</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>STK4, KRS2, MACROPHAGE STIMULATING 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>19p13.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6789</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>604995</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000101189</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q13043</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>487 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~56 kDa</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Small molecule inhibitors</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Kinase inhibitors</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Experimental</td>
</tr>
<tr>
<td class="label">Natural compounds</td>
<td>Investigation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's Disease</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's disease</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">94 edges</a></td>
</tr>
</table>
The MST1 gene (Macrophage Stimulating 1), also known as STK4 in some nomenclature, encodes a serine/threonine kinase that belongs to the Hippo signaling pathway. This gene plays crucial roles in cellular processes including apoptosis, cell proliferation, differentiation, stress response, and tissue homeostasis. In the nervous system, MST1 is involved in neuronal development, synaptic plasticity, and neurodegeneration. The gene is located on chromosome 19p13.3 and is expressed widely across various tissues, with particularly high expression in the brain and spinal cord. [@neurodegenerative]
MST1 (Macrophage Stimulating 1), also designated STK4 (Serine/Threonine Kinase 4), is a key component of the Hippo signaling pathway, which is evolutionarily conserved from Drosophila to mammals. This pathway regulates organ size through modulation of cell proliferation, apoptosis, and stem cell self-renewal. In [neurons](/entities/neurons), MST1 functions as a pro-apoptotic kinase that is activated by various cellular stresses and contributes to neurodegeneration in Alzheimer's disease, Parkinson's disease, and other neurological disorders. [@alzheimers]
The MST1 protein acts as a tumor suppressor and is frequently dysregulated in cancer. However, in neurons, its activation can lead to pathological cell death, making it a dual-edged sword in neurodegeneration research. [@nih]
The MST1 protein contains several functional domains:
MST1 undergoes several regulatory modifications:
MST1 is a serine/threonine kinase with the following characteristics:
MST1 is expressed in various tissues:
MST1 expression is regulated by:
MST1 is implicated in AD pathogenesis through multiple mechanisms:
In PD, MST1 contributes to:
MST1 in ALS:
MST1 promotes neuronal apoptosis through:
MST1 contributes to neuroinflammation:
In synapses, MST1:
Targeting MST1 in neurodegeneration:
MST1 as a biomarker:
MST1 knockout mice:
MST1 deficiency:
The study of Mst1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The following diagram shows the key molecular relationships involving MST1 Gene discovered through SciDEX knowledge graph analysis: